Boston bank becomes biggest shareholder of Clovis Oncology
BOULDER — State Street Corp., one of the world’s largest financial firms, has purchased a 10 percent stake in Clovis Oncology Inc. (Nasdaq: CLVS), becoming its largest shareholder in the process.
The Boston-based bank acquired 5,333,649 shares of the Boulder cancer therapy company for a 10.06 percent share, according to filings with the U.S. Securities and Exchange Commission.
SSGA Funds Management Inc., a State Street subsidiary, holds 4,454,933 of those shares, totalling an 8.4 percent stake in all of Clovis’ shares. Clovis currently has 53 million shares outstanding.
SPONSORED CONTENT
Business Cares: April 2024
In Colorado, 1 in 3 women, 1 in 3 men and 1 in 2 transgender individuals will experience an attempted or completed sexual assault in their lifetime. During April, we recognize Sexual Assault Awareness Month with the hopes of increasing conversations about this very important issue.
The transaction makes State Street the largest owner of Clovis stock, edging out the 5,239,304 shares owned by Palo Alto Investors LP, according to ownership data compiled by Nasdaq.
BOULDER — State Street Corp., one of the world’s largest financial firms, has purchased a 10 percent stake in Clovis Oncology Inc. (Nasdaq: CLVS), becoming its largest shareholder in the process.
The Boston-based bank acquired 5,333,649 shares of the Boulder cancer therapy company for a 10.06 percent share, according to filings with the U.S. Securities and Exchange Commission.
SSGA Funds Management Inc., a State Street subsidiary, holds 4,454,933 of those shares, totalling an 8.4 percent stake in all of Clovis’ shares. Clovis currently has 53 million shares outstanding.
The transaction makes State Street the largest…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
